Literature DB >> 11766145

Diagnosis and management of vulvar and vaginal intraepithelial neoplasia.

R J Cardosi1, J J Bomalaski, M S Hoffman.   

Abstract

Vulvar intraepithelial neoplasia and VAIN present unique challenges to the practicing gynecologist. VIN may produce distressing symptoms and undergo malignant conversion. A high index of suspicion and liberal use of biopsy are required to make the diagnosis. The approach to therapy for VIN has been reviewed. Treatment should be tailored to each individual patient and may include a period of expectant observation. Variations and combinations are used whenever necessary to preserve normal function and anatomy. Frequent surveillance is a must because recurrence rates are high, especially with multifocal disease in young women. Although VAIN accounts for less than 0.5% of lower genital tract neoplasia, the frequency of its detection is increasing, especially in younger patients. These lesions are most commonly found in the upper third of the vagina and are often multifocal in nature. The close proximity of the upper vagina to the rectum, bladder, and ureters makes treatment difficult. The occult invasion rate may be as high as 28%, and a wide variety of therapies are available. As is true for VIN, recurrence is not uncommon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766145     DOI: 10.1016/s0889-8545(05)70229-1

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  6 in total

1.  Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation.

Authors:  Sung-Jong Lee; Liwen Song; Ming-Chieh Yang; Chih-Ping Mao; Benjamin Yang; Andrew Yang; Jessica Jeang; Shiwen Peng; T-C Wu; Chien-Fu Hung
Journal:  Vaccine       Date:  2015-02-19       Impact factor: 3.641

2.  Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Authors:  Ruey-Shyang Soong; Liwen Song; Janson Trieu; Jayne Knoff; Liangmei He; Ya-Chea Tsai; Warner Huh; Yung-Nien Chang; Wen-Fang Cheng; Richard B S Roden; T-C Wu; Cornelia L Trimble; Chien-Fu Hung
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

3.  Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease.

Authors:  Shiwen Peng; Jin Qiu; Andrew Yang; Benjamin Yang; Jessica Jeang; Joshua W Wang; Yung-Nien Chang; Cory Brayton; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Cell Biosci       Date:  2016-02-25       Impact factor: 7.133

4.  A Retrospective Study of Cytology, High-Risk HPV, and Colposcopy Results of Vaginal Intraepithelial Neoplasia Patients.

Authors:  Qing Cong; Yu Song; Qing Wang; Hongwei Zhang; Shujun Gao; Long Sui
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

5.  Photodynamic therapy for gynecological diseases and breast cancer.

Authors:  Natashis Shishkova; Olga Kuznetsova; Temirbolat Berezov
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

6.  Abnormal Pap Smear and Diagnosis of High-Grade Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.

Authors:  Francesco Sopracordevole; Francesca Mancioli; Nicolò Clemente; Giovanni De Piero; Monica Buttignol; Giorgio Giorda; Andrea Ciavattini
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.